Cargando…
SARS-CoV-2 Delta VOC in Scotland: demographics, risk of hospital admission, and vaccine effectiveness
Autores principales: | Sheikh, Aziz, McMenamin, Jim, Taylor, Bob, Robertson, Chris |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier Ltd.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8201647/ https://www.ncbi.nlm.nih.gov/pubmed/34139198 http://dx.doi.org/10.1016/S0140-6736(21)01358-1 |
Ejemplares similares
-
BNT162b2 and ChAdOx1 nCoV-19 Vaccine Effectiveness against Death from the Delta Variant
por: Sheikh, Aziz, et al.
Publicado: (2021) -
Severity of omicron variant of concern and effectiveness of vaccine boosters against symptomatic disease in Scotland (EAVE II): a national cohort study with nested test-negative design
por: Sheikh, Aziz, et al.
Publicado: (2022) -
AZD1222-induced neutralising antibody activity against SARS-CoV-2 Delta VOC
por: Wall, Emma C, et al.
Publicado: (2021) -
Severity of Omicron BA.5 variant and protective effect of vaccination: national cohort and matched analyses in Scotland
por: Robertson, Chris, et al.
Publicado: (2023) -
Modelling the population effectiveness of the national seasonal influenza vaccination programme in Scotland: The impact of targeting all individuals aged 65 years and over
por: Corson, Stephen, et al.
Publicado: (2019)